Boehringer Ingelheim
Marc Hasson is a seasoned executive with extensive experience in the pharmaceutical industry, currently serving as Head of Emerging Markets Human Pharma at Boehringer Ingelheim since September 2014, where innovative healthcare solutions are developed for Emerging Markets. Previously, Marc held the role of Country Managing Director for Brazil and Corporate Region Manager for both Asia, Middle East/Africa and Latin America at Ipsen from April 2005 to August 2014, overseeing significant operational transformations. Earlier positions include serving as Strategic Planning Senior Director and Commercial Director in Brazil at sanofi-aventis, and various financial leadership roles at Hoechst Marion Roussel and Roussel Uclaf. Marc holds an MBA in Finance from ESSEC Business School and completed the CEDEP General Management Program at INSEAD.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.